141: A planning comparison study implementing "AAA" heterogeneity calculation algorithm for stage II/III non-small cell lung cancer (NSCLC): is IMRT always the solution?. (January 2015) - Aznar-Garcia, L.; Wright, S.; Coppock, K.; Sridhar, T.; Ahmed, S.